This inventor holds 6 USPTO granted patents. Top assignees: Cephalon, Inc., Kyowa Hakko Kogyo Co., Ltd., Kyowa Hakko Kogyo. Active years: 1995-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Landenberg, PA (US) (1995)
- West Chester, PA (US) (1995 - 1998)
Company Filing History:
6 out of 248 
4 out of 730 
1 out of 9 Years Active: 1995-1998
Title: The Innovative Contributions of Jill M Roberts-Lewis
Introduction
Jill M Roberts-Lewis is a prominent inventor based in Landenberg, PA (US), known for her significant contributions to the field of neurological research. With a total of six patents to her name, she has made remarkable strides in developing treatments for neurological disorders.
Latest Patents
Her latest patents focus on protein kinase inhibitors for the treatment of neurological disorders. The inventions feature novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. Additionally, these patents include methods for treating diseased neuronal cells through the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.
Career Highlights
Throughout her career, Jill has worked with notable companies such as Cephalon, Inc. and Kyowa Hakko Kogyo Co., Ltd. Her work has been instrumental in advancing the understanding and treatment of neurological conditions.
Collaborations
Jill has collaborated with esteemed colleagues, including Michael E Lewis and James C Kauer, further enhancing her research and innovation in the field.
Conclusion
Jill M Roberts-Lewis exemplifies the spirit of innovation in the realm of neurological research. Her contributions through her patents and collaborations continue to pave the way for advancements in treatment options for neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile